Micronutrients in Pregnancy as a Risk Factor for Diabetes and Effects on Mother and Baby
PRiDE
1 other identifier
observational
4,500
1 country
1
Brief Summary
There is a rapidly escalating epidemic of obesity and type 2 diabetes across the world, with the fastest rise occurring in low- and middle-income countries. India not only has one of the highest rates in the world, but the disease starts at a younger age and lower levels of body weight than in UK white caucasians. Among city-dwelling Indians, approximately 8% of people aged 30-40 years already have diabetes. This is creating a heavy burden of disease and disability, and an intolerable economic burden through medical costs and lost earnings. Until now, efforts to prevent diabetes have mainly focussed on modifying the diet, lifestyle and activity of at-risk adults (for example those who are overweight, have a family history of diabetes or already have high blood sugar). However, recent research has indicated that factors acting in early life (during development in the womb) place an individual at risk of later diabetes. These include maternal malnutrition and low birthweight, and diabetes in the mother during pregnancy. Our research has shown that Indian mothers often have low vitamin B12 levels, which in turn causes high blood levels of a harmful metabolite (homocysteine). We have shown that these mothers get more diabetes in pregnancy. Their children are more likely to born with a low birth weight, and develop more body fat and higher plasma insulin levels during childhood, which are signs of higher diabetes risk in later life. The risk is increased further if the mother has normal or high status for another B vitamin, folate. Thus, we have shown, for the first time a link between a specific nutritional deficiency in the mother and diabetes risk in the next generation. One possible mechanism for the effect of maternal nutrition on risk of diabetes in her children is through epigenetic effects, whereby the nutritional environment during early development affects the switches that control gene expression. Since these switches are passed on via either parent, we think it is possible that paternal vitamin B12 status could also be important.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 22, 2016
CompletedFirst Posted
Study publicly available on registry
January 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedJanuary 4, 2017
December 1, 2016
4.8 years
December 22, 2016
December 29, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Differences in B12 levels between GDM and Controls
5 Years
Secondary Outcomes (7)
Differences in B12 levels in South Asians and White Caucasians
5 years
Differences between offspring birth weight between GDM and controls
5 years
Differences between offspring adiposity between GDM and controls
5 years
Differences between offspring birth weight between South Asians and White Caucasians
5 years
Differences between offspring adiposity between South Asians and White Caucasians
5 years
- +2 more secondary outcomes
Other Outcomes (7)
Psychological impact of the diagnosis of GDM in each ethnicity
5 years
Role of sedentary behavior on incident GDM
5 years
Role of physical activity on incident GDM
5 years
- +4 more other outcomes
Eligibility Criteria
All pregnant women between 18-75 years of age who satisfy NICE criteria for GDM screening
You may qualify if:
- Pregnant women \<16 years of age
- High risk for GDM (at least 1 of the risk factors) - BMI \>30
- Previous GDM
- First degree relatives with GDM
- Previous unexplained still birth
- Previous baby \>4.5kg
- PCOS
- Ethnic minority groups
- Age \>35years
You may not qualify if:
- Pregestational Type 1 or Type 2 Diabetes
- Diagnosis of B12 or folate deficiency in the current pregnancy
- Previous pregnancies with NTDs
- Diagnosis of severe aneamia (\<10g/dL)
- Vitamin B12 injections in the previous 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Warwicklead
- George Eliot Hospital NHS Trustcollaborator
Study Sites (1)
University of Warwick
Coventry, Coventry, CV47AL, United Kingdom
Related Publications (1)
Saravanan P, Sukumar N, Adaikalakoteswari A, Goljan I, Venkataraman H, Gopinath A, Bagias C, Yajnik CS, Stallard N, Ghebremichael-Weldeselassie Y, Fall CHD. Association of maternal vitamin B12 and folate levels in early pregnancy with gestational diabetes: a prospective UK cohort study (PRiDE study). Diabetologia. 2021 Oct;64(10):2170-2182. doi: 10.1007/s00125-021-05510-7. Epub 2021 Jul 22.
PMID: 34296321DERIVED
Biospecimen
Plasma, serum and whole blood for isolating DNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ponnusamy Saravanan, FRCP PhD
University of Warwick
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Clinical Professor
Study Record Dates
First Submitted
December 22, 2016
First Posted
January 4, 2017
Study Start
September 1, 2012
Primary Completion
June 1, 2017
Study Completion
June 1, 2018
Last Updated
January 4, 2017
Record last verified: 2016-12